High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study uses a sequence of high-dose chemotherapy drugs and a stem cell transplant to
treat multiple myeloma. The study is being performed to evaluate the efficacy and side
effects of treatment. Specifically, the study is designed to reduce the risk of interstitial
pneumonitis.